AstraZeneca's drug pipeline has evolved significantly under CEO Pascal Soriot since he took over more than a decade ago, and new technologies such as antibody-drug conjugates are making up a rising proportion of its portfolio of future cancer therapies....
ASTRAZENECA PLC AZN Company page - Search stock, chart, recent trades, company information, trading information, company news, fundamentals
So that's an important one as well and equally, we are putting a lot of resources behind the product in order to make that a multi-billion-dollar opportunity and equally, of course, we're also looking forward to the outcome trial of Breztri moving forward in the cardiovascular space. So ...
But right now, your commercial presence there seems a little bit under-resourced. And just wondering in terms of your commitment to that space and growing that space, really where you see sort of the -- your vision for that area and growing there. How committed are you to that? And how...
K+S cuts 2023 profit outlook for third time this year 10 min ago RE Amazon has drawn thousands to try its AI service competing with Microsoft, Google 10 min ago RE Canada financial regulator proposes new capital guidelines for crypto assets 11 min ago RE Mexico working with U.S. o...
Astra Space, Inc. (ASTR) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ETCompany ParticipantsChris Kemp - Founder, Chairman, and CEOKelyn Brannon -...
confusion as to where we are in the life cycle of an HER2 and kind of the next drivers that we see going forward. And then the question on obesity is really just more strategic. And this is for Pascal as much as anything, how are you thinking about the overall obesity space ...
We remain, as we see it, still the leaders within this space. That said, it is a pretty tight share split among the three players as we see it within that space. In terms of now switching to the commercial opportunity for TROPION-Breast01, I think that maybe the primary thing that ...